Shedir Pharma Group
Develops and sells pharmaceutical, nutraceutical, and dermo-cosmetic products in Italy & Spain.
SHE | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005379620
- LEI:
- 81560092B300849E9017
- Country:
- Italy
- Address:
- VIA BAGNULO, 95, 80063 PIANO DI SORRENTO
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Shedir Pharma Group S.p.A. is a holding company operating in the pharmaceutical and nutraceutical sectors. The group specializes in the research, formulation, development, and commercialization of health and wellness products. Its portfolio includes food supplements, dermo-cosmetics, medical devices, and, through its subsidiary Dymalife Pharmaceutical, prescription drugs. A key focus is on innovation, developing unique and patented products through dedicated R&D subsidiaries like Neilos and Dymalife Research. The company's offerings cover approximately 15 therapeutic areas and are distributed through an extensive network of exclusive sales agents in Italy and Spain. The group was listed on the AIM Italia market in 2019.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-01-23 15:09 |
Delisting Announcement
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
|
Italian | 165.5 KB | ||
| 2025-01-13 17:33 |
Delisting Announcement
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
|
Italian | 182.0 KB | ||
| 2025-01-10 18:00 |
M&A Activity
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
|
Italian | 159.1 KB | ||
| 2025-01-09 19:17 |
M&A Activity
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
|
Italian | 147.6 KB | ||
| 2025-01-07 18:45 |
M&A Activity
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
|
Italian | 150.6 KB | ||
| 2025-01-03 17:36 |
Regulatory News Service
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
|
Italian | 156.6 KB | ||
| 2024-12-27 17:49 |
M&A Activity
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
|
Italian | 156.4 KB | ||
| 2024-12-20 17:49 |
M&A Activity
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
|
Italian | 156.6 KB | ||
| 2024-12-13 17:42 |
Declaration of Voting Results & Voting Rights Announcements
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
|
Italian | 157.4 KB | ||
| 2024-12-06 17:49 |
M&A Activity
COMUNICAZIONE AVENTE A OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITA…
|
Italian | 137.0 KB | ||
| 2024-11-29 18:20 |
Proxy Solicitation & Information Statement
COMUNICAZIONE AVENTE A OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITA…
|
Italian | 340.2 KB | ||
| 2024-11-29 18:18 |
Delisting Announcement
COMUNICAZIONE AVENTE A OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITA…
|
Italian | 127.5 KB | ||
| 2024-11-29 18:16 |
Prospectus
COMUNICAZIONE AVENTE A OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITA…
|
Italian | 1.1 MB | ||
| 2024-09-26 18:01 |
Interim Report
SHEDIR PHARMA GROUP - AL 30 GIUGNO 2024 FATTURATO ED EBITDA CONSOLIDATI IN AUME…
|
Italian | 769.4 KB | ||
| 2024-09-02 17:56 |
M&A Activity
Dymalife finalizza l'acquisizione di un Ramo d'Azienda
|
Italian | 377.0 KB |
Automate Your Workflow. Get a real-time feed of all Shedir Pharma Group filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Shedir Pharma Group via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
